Talk:Phenylephrine: Difference between revisions
>Xbdab Added more toxicity information |
>SquaricAcid m phenylephrine has no psychedelic action and is definitely not a tryptamine (fixed this) |
||
(15 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
{{headerpanel|{{Approval}}}} | {{headerpanel|{{Approval}}}} | ||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/ | {{SubstanceBox | ||
<!-- Special Parameters --> | |||
|displayClasses={{{displayClasses|}}} | |||
|MaterialTable_MaxWidth=250px | |||
|MaterialTable_Title={{PAGENAME}} | |||
<!-- Modules --> | |||
|ModuleSource=false | |||
|ModuleCombination=false | |||
|ModuleStructure=true | |||
|ModuleNomenclature=true | |||
|ModuleClassMembership=true | |||
|ModuleROA=true | |||
<!-- Source --> | |||
|PhotoImageFile= | |||
|PhotoImageWidth= | |||
|PhotoImageCaption= | |||
<!-- Combination --> | |||
|CombinationImage1_Caption= | |||
|CombinationImage1_File= | |||
|CombinationImage1_Width= | |||
|CombinationImage2_Caption= | |||
|CombinationImage2_File= | |||
|CombinationImage2_Width= | |||
|CombinationImage3_Caption= | |||
|CombinationImage3_File= | |||
|CombinationImage3_Width= | |||
<!-- Structure --> | |||
|MolecularStructureCaption= | |||
|SkeletalImageFile=File:Phenylephrine_Structural_Formula_V1.svg | |||
|3DImageFile= | |||
|3DImageWidth= | |||
<!-- Nomenclature --> | |||
|NameCommon=Phenylephrine | |||
|NameSubstitution=Neo-synephrine, m-Synephrine, β-HO-N-Me-3-HPEA | |||
|NameSystematic=3-[1-Hydroxy-2-(methylamino)ethyl]phenol | |||
<!-- Class Membership --> | |||
|EffectClass=[[psychoactive class::Stimulant]] | |||
|ChemicalClass=[[chemical class::Phenethylamine]] | |||
<!-- Dosage/Duration per ROA --> | |||
|OralROA=true | |||
|OralROA_Collapsed=true | |||
|OralROA_Caption= | |||
|OralROA_Bioavailability=[[Oral min bioavailability::38]]% - [[Oral max bioavailability::38]]% | |||
|OralROA_Microdose= | |||
|OralROA_Threshold=[[Oral threshold dose::3]] - [[Oral dose units::mg]] | |||
|OralROA_Light=[[Oral min light dose::5]] - [[Oral max light dose::9]] mg | |||
|OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::y]] mg | |||
|OralROA_Strong=[[Oral min strong dose::x]] - [[Oral max strong dose::59]] mg | |||
|OralROA_Heavy=[[Oral heavy dose::60]] mg + | |||
|OralROA_TimelineFile= | |||
|OralROA_TimelineWidth= | |||
|OralROA_Duration=[[Oral min total time::4]] - [[Oral max total time::4]] [[Oral total time units::hours]] | |||
|OralROA_Onset=[[Oral min onset time::20]] - [[Oral max onset time::20]] [[Oral onset time units::minutes]] | |||
|OralROA_Comeup=[[Oral min comeup time::x]] - [[Oral max comeup time::y]] [[Oral comeup time units::minutes]] | |||
|OralROA_Peak=[[Oral min peak time::x]] - [[Oral max peak time::y]] [[Oral peak time units::hours]] | |||
|OralROA_Offset=[[Oral min offset time::x]] - [[Oral max offset time::y]] [[Oral offset time units::hours]] | |||
|OralROA_Aftereffects=[[Oral min afterglow time::x]] - [[Oral max afterglow time::y]] [[Oral afterglow time units::hours]] | |||
|InsufflatedROA=true | |||
|InsufflatedROA_Collapsed=false | |||
|InsufflatedROA_Caption= | |||
|InsufflatedROA_Bioavailability= | |||
|InsufflatedROA_Microdose= | |||
|InsufflatedROA_Threshold=[[Insufflated threshold dose::x]] - [[Insufflated dose units::mg]] | |||
|InsufflatedROA_Light=[[Insufflated min light dose::x]] - [[Insufflated max light dose::y]] mg | |||
|InsufflatedROA_Common=[[Insufflated min common dose::x]] - [[Insufflated max common dose::y]] mg | |||
|InsufflatedROA_Strong=[[Insufflated min strong dose::x]] - [[Insufflated max strong dose::y]] mg | |||
|InsufflatedROA_Heavy=[[Insufflated heavy dose::x]] mg + | |||
|InsufflatedROA_TimelineFile= | |||
|InsufflatedROA_TimelineWidth= | |||
|InsufflatedROA_Duration=[[Insufflated min total time::x]] - [[Insufflated max total time::y]] [[Insufflated total time units::hours]] | |||
|InsufflatedROA_Onset=[[Insufflated min onset time::x]] - [[Insufflated max onset time::y]] [[Insufflated onset time units::minutes]] | |||
|InsufflatedROA_Comeup=[[Insufflated min comeup time::x]] - [[Insufflated max comeup time::y]] [[Insufflated comeup time units::minutes]] | |||
|InsufflatedROA_Peak=[[Insufflated min peak time::x]] - [[Insufflated max peak time::y]] [[Insufflated peak time units::hours]] | |||
|InsufflatedROA_Offset=[[Insufflated min offset time::x]] - [[Insufflated max offset time::y]] [[Insufflated offset time units::hours]] | |||
|InsufflatedROA_Aftereffects=[[Insufflated min afterglow time::x]] - [[Insufflated max afterglow time::y]] [[Insufflated afterglow time units::hours]] | |||
}} | |||
'''Phenylephrine''' is used as a decongestant sold as an oral medicine or as a nasal spray. It is a common ingredient in over-the-counter decongestants in the United States. | '''Phenylephrine''' is used as a decongestant sold as an oral medicine or as a nasal spray. It is a common ingredient in over-the-counter decongestants in the United States. | ||
Line 15: | Line 103: | ||
Phenylephrine was patented in 1927 and came into medical use in 1938. It is available as a generic medication | Phenylephrine was patented in 1927 and came into medical use in 1938. It is available as a generic medication | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | {{pharmacology}} | ||
Line 22: | Line 108: | ||
==Subjective effects== | ==Subjective effects== | ||
{{Preamble/SubjectiveEffects}} | {{Preamble/SubjectiveEffects}} | ||
{{effects/base | {{effects/base | ||
Line 28: | Line 113: | ||
|{{effects/physical| | |{{effects/physical| | ||
*'''[[Effect::Pupil dilation]]''' | *'''[[Nasal decongestion]]''' | ||
*'''[[Effect::Pupil dilation]]''' - Most common when used in eye drops | |||
*'''[[Effect::Increased blood pressure]]''' | *'''[[Effect::Increased blood pressure]]''' | ||
*'''[[Effect::Abnormal heartbeat]]''' | *'''[[Effect::Abnormal heartbeat]]''' - This effect is most prevalent in high doses | ||
*'''[[Effect::Headache]]''' | *'''[[Effect::Headache]]''' - This effect is most prevalent in high doses | ||
*'''[[Effect::Skin flushing]]''' | *'''[[Effect::Skin flushing]]''' | ||
*'''[[Effect::Appetite suppression]]''' | *'''[[Effect::Appetite suppression]]''' | ||
*'''[[Effect::Dizziness]]''' | *'''[[Effect::Dizziness]]''' - This effect is most prevalent in high doses | ||
*'''[[Effect::Nausea]]''' | *'''[[Effect::Nausea]]''' | ||
}} | }} | ||
Line 41: | Line 127: | ||
*'''[[Effect::Wakefulness]]''' | *'''[[Effect::Wakefulness]]''' | ||
*'''[[Effect::Anxiety]]''' | *'''[[Effect::Anxiety]]''' - This effect is most prevalent in high doses | ||
*'''[[Effect::Insomnia]]''' - This effect is most prevalent in high doses | |||
}} | }} | ||
}} | }} | ||
Line 59: | Line 146: | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||
{{DangerousInteractions}} | {{DangerousInteractions}} | ||
The increase in blood pressure effect of phenylephrine may be increased by drugs such as '''monoamine oxidase inhibitors''', '''tricyclic antidepressants''', and '''hydrocortisone'''. Patients taking these medications may need a lower dose of phenylephrine to achieve a similar increase in blood pressure. | The increase in blood pressure effect of phenylephrine may be increased by drugs such as '''monoamine oxidase inhibitors''', '''tricyclic antidepressants''', and '''hydrocortisone'''. Patients taking these medications may need a lower dose of phenylephrine to achieve a similar increase in blood pressure. | ||
Line 76: | Line 162: | ||
* [https://en.wikipedia.org/wiki/Phenylephrine Phenylephrine (Wikipedia)] | * [https://en.wikipedia.org/wiki/Phenylephrine Phenylephrine (Wikipedia)] | ||
* [https://www.erowid.org/experiences/subs/exp_Pharms_Phenylephrine.shtml Phenylephrine (Erowid Vault)] | * [https://www.erowid.org/experiences/subs/exp_Pharms_Phenylephrine.shtml Phenylephrine (Erowid Vault)] | ||
* [https://isomerdesign.com/PiHKAL/explore.php?id=6157&name=Phenylephrine Phenylephrine (Isomer Design)] | |||
* [https://www.drugs.com/mtm/phenylephrine.html Phenylephrine (Drugs.com)] | * [https://www.drugs.com/mtm/phenylephrine.html Phenylephrine (Drugs.com)] | ||
* [https://pubchem.ncbi.nlm.nih.gov/compound/6041 Phenylephrine (Pubchem)] | * [https://pubchem.ncbi.nlm.nih.gov/compound/6041 Phenylephrine (Pubchem)] |